Physician

Jason Michael Poston, MD

According to 2025 Medicare claims, Jason Poston, MD (NPI: 1457527772) practices anesthesiology in the Idaho Falls, ID market, with the plurality of this provider's patient population coming from Bonneville, ID. This provider's primary affiliated billing organization is MOUNTAIN VIEW HOSPITAL LLC (NPI: 1669462362; TIN: 820516012) and primary practice location at 83404-4978. Poston is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Poston's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 553 traditional Medicare patients, billed 2,491 HCPCS/CPT codes, and received $183,231 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,258 prescription claims across 384 beneficiaries totaling $54,827 in drug costs, led by Buprenorphine (Buprenorphine). 2021 DME data shows 24 claims. Open Payments data shows 40 records totaling $1,383. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $328,134 to $183,231. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $76,001 and ending at $54,827. For DME billing, reported payments moved sharply higher in recent years, from $1,408 to $20,716.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	511	13,178	$328,134
2016	626	3,302	$218,457
2017	651	3,366	$249,601
2018	619	3,593	$279,422
2019	580	3,140	$245,536
2020	566	2,945	$234,029
2021	596	3,226	$238,000
2022	598	3,145	$240,632
2023	633	2,789	$211,798
2024	553	2,491	$183,231

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	381	1,314	$76,001
2016	348	965	$59,945
2017	309	869	$53,736
2018	295	1,079	$64,592
2019	266	917	$47,008
2020	324	1,242	$62,907
2021	327	1,168	$50,951
2022	426	1,578	$65,443
2023	474	1,694	$78,994
2024	384	1,258	$54,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$1,047
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	24	$1,374
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	128	128	$86
27096	Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance	102	130	$75
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	142	240	$67
62323	Injection of substance into lower spine canal using imaging guidance	103	113	$65
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	103	111	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine	Buprenorphine	30	846	$7,542
Movantik	Naloxegol Oxalate	12	420	$5,628
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	210	5,413	$4,362
Pregabalin	Pregabalin	86	2,979	$3,865
Fentanyl	Fentanyl	37	1,080	$3,473

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$568	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$814	Boston Scientific Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason Michael Poston, MD?

Tedicare shows public-source Medicare data for Jason Michael Poston, MD (NPI 1457527772), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Michael Poston, MD have ACO affiliation data?

Jason Michael Poston, MD is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Jason Michael Poston, MD?

Jason Michael Poston, MD is linked to MOUNTAIN VIEW HOSPITAL LLC (billing NPI 1669462362) in the available physician profile data.

Does Jason Michael Poston, MD have Open Payments data?

Jason Michael Poston, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.